Clinical Trial Update: Evaluation of (R)-Roscovitine Safety and Effects in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and effects of (R)-roscovitine in subjects with cystic fibrosis who are homozygous for the F508del-CFTR mutation; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• (R)-roscovitine (seliciclib) (roscovitine)

Snippet

Sponsor: University Hospital, Brest | Conditions: Cystic Fibrosis | Phase 2 | Status: TERMINATED